Utility of a rapid assay for prostaglandin E-major urinary metabolite as a biomarker in pediatric ulcerative colitis [PDF]
Prostaglandin E-major urinary metabolite (PGE-MUM) is a urinary biomarker reflecting ulcerative colitis (UC) activity. This prospective observational study aimed to evaluate the usefulness of PGE-MUM via rapid chemiluminescent enzyme immunoassay in ...
Shin-ichiro Hagiwara +20 more
doaj +4 more sources
Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis [PDF]
Background Prostaglandin E-major urinary metabolite (PGE-MUM) may be a novel biomarker for evaluating disease activity in ulcerative colitis (UC). We compared its usefulness to that of the fecal immunochemical occult blood test (FIT). Methods PGE-MUM and
Natsuki Ishida +12 more
doaj +5 more sources
Comparison between Prostaglandin E-major urinary metabolite and C-reactive protein levels to reflect endoscopic scores in patients with ulcerative colitis [PDF]
Prostaglandin E-major urinary metabolite (PGE-MUM) and C-reactive protein (CRP) are useful biomarkers in patients with ulcerative colitis. However, whether changes in endoscopic scores over time are reflected in the values of these biomarkers has not ...
Natsuki Ishida +9 more
doaj +5 more sources
Introduction: Prostaglandin E-major urinary metabolite (PGE-MUM) may be a good biomarker of inflammation and useful in monitoring diseases, without the necessity of invasive sampling. To see whether inflammation in muscles occurs during physical exercise,
Isao Okayasu +9 more
doaj +3 more sources
Prostaglandin E-major urinary metabolite as a potential biomarker of muscle inflammation following physical exercise, considering gender differences [PDF]
Prostaglandin E-major urinary metabolite (PGE-MUM) may be a useful biomarker for assessing muscle inflammation caused by physical exercise. To explore this, both male and female volunteer university students (n = 18) performed gradual loading treadmill ...
Isao Okayasu +4 more
doaj +3 more sources
Diabetic nephropathy is a major complication of diabetes mellitus, and thus novel biomarkers are desired to evaluate the presence and progression of diabetic nephropathy.
Yoshifumi Morita +5 more
doaj +3 more sources
Clinical Determinants and Bone Metabolic Correlates of 24-h Urinary PGE2 and PGEM Excretion in Chinese Adults: A Multicenter Cross-Sectional Study [PDF]
Background: Prostaglandin E2 (PGE2) is a key lipid mediator involved in inflammation and bone homeostasis. Its systemic production is reliably reflected by 24 h urinary excretion of PGE2 (U-PGE2) and its major metabolite (U-PGEM).
Qi Lu, Li Shen, Yang Xu, Zhenlin Zhang
doaj +2 more sources
Optimal positioning of biomarkers according to ulcerative colitis activity [PDF]
The diagnostic performance and clinical utility of fecal calprotectin (FC), fecal immunochemical occult blood test (FIT), leucine-rich alpha-2 glycoprotein (LRG), C-reactive protein (CRP), and prostaglandin E-major urinary metabolite (PGE-MUM) as ...
Natsuki Ishida +10 more
doaj +2 more sources
Effect of Dysglycemia on Urinary Lipid Mediator Profiles in Persons With Pulmonary Tuberculosis
BackgroundOxidized lipid mediators such as eicosanoids play a central role in the inflammatory response associated with tuberculosis (TB) pathogenesis. Diabetes mellitus (DM) leads to marked changes in lipid mediators in persons with TB.
María B. Arriaga +56 more
doaj +1 more source
Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
The number of patients with inflammatory bowel disease (IBD) is increasing worldwide. Endoscopy is the gold standard to assess the condition of IBD. The problem with this procedure is that the burden and cost on the patient are high.
Kohei Wagatsuma +2 more
doaj +1 more source

